Natixis’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-37,147
| Closed | -$60K | – | 1279 |
|
|
2022
Q3 | $60K | Buy |
37,147
+22,147
| +148% | +$35.8K | ﹤0.01% | 946 |
|
|
2022
Q2 | $30K | Sell |
15,000
-42,830
| -74% | -$85.7K | ﹤0.01% | 998 |
|
|
2022
Q1 | $135K | Buy |
57,830
+42,100
| +268% | +$98.3K | ﹤0.01% | 1118 |
|
|
2021
Q4 | $73K | Buy |
+15,730
| New | +$73K | ﹤0.01% | 1194 |
|
|
2021
Q2 | – | Sell |
-10,700
| Closed | -$88K | – | 1175 |
|
|
2021
Q1 | $88K | Sell |
10,700
-301,100
| -97% | -$2.48M | ﹤0.01% | 1043 |
|
|
2020
Q4 | $2.13M | Buy |
311,800
+263,040
| +539% | +$1.8M | 0.01% | 674 |
|
|
2020
Q3 | $544K | Buy |
+48,760
| New | +$544K | ﹤0.01% | 598 |
|